| Lisa Zucker, Pa | |
|
3874 Sheridan St Hollywood FL 33021-3634 | |
| (954) 834-3570 | |
| Not Available |
| Full Name | Lisa Zucker, Pa |
|---|---|
| Speciality | Social Worker |
| Location | 3874 Sheridan St, Hollywood, Florida |
| Authorized Official Name and Position | Lisa Zucker (PRESIDENT OF PA) |
| Authorized Official Contact | 9548343570 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Zucker, Pa 3874 Sheridan St Hollywood FL 33021-3634 Ph: (954) 834-3570 | Lisa Zucker, Pa 3874 Sheridan St Hollywood FL 33021-3634 Ph: (954) 834-3570 |
| NPI Number | 1619268794 |
|---|---|
| Provider Enumeration Date | 04/25/2011 |
| Last Update Date | 04/19/2024 |
| Certification Date | 04/19/2024 |
| Medicare PECOS PAC ID | 1951587955 |
|---|---|
| Medicare Enrollment ID | O20110509000356 |
News Archive
"The U.S. development community is pronouncing itself 'thrilled' with the Obama administration's recently unveiled new development policy," Politico's Laura Rozen reports on her blog, which examines reaction to President Barack Obama's speech at the U.N. Summit on the Millennium Development Goals (MDGs) last week.
Adoption of health information technology is examined as new computer application development and adoption change how doctors deliver care.
On March 28, leading experts across multiple disciplines will convene at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes to review the latest research on bariatric surgery as a treatment option.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).
Atherosclerosis is a disease of the major arterial blood vessels. It is one of the major causes of heart attack and stroke. The proinflammatory molecule IL-1 has been linked to atherosclerosis and a clinical trial has been launched in which an antibody specific for IL-1-beta is being studied for its effects on the severe clinical complications of atherosclerosis.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619268794 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | SW9233 (Florida) | Primary |
| Provider Name | Lisa M Zucker |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1558425629 PECOS PAC ID: 3375729379 Enrollment ID: I20110526000664 |
News Archive
"The U.S. development community is pronouncing itself 'thrilled' with the Obama administration's recently unveiled new development policy," Politico's Laura Rozen reports on her blog, which examines reaction to President Barack Obama's speech at the U.N. Summit on the Millennium Development Goals (MDGs) last week.
Adoption of health information technology is examined as new computer application development and adoption change how doctors deliver care.
On March 28, leading experts across multiple disciplines will convene at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes to review the latest research on bariatric surgery as a treatment option.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).
Atherosclerosis is a disease of the major arterial blood vessels. It is one of the major causes of heart attack and stroke. The proinflammatory molecule IL-1 has been linked to atherosclerosis and a clinical trial has been launched in which an antibody specific for IL-1-beta is being studied for its effects on the severe clinical complications of atherosclerosis.
› Verified 5 days ago
| Provider Name | Kim Brink |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1285970145 PECOS PAC ID: 1951346980 Enrollment ID: I20130912000580 |
News Archive
"The U.S. development community is pronouncing itself 'thrilled' with the Obama administration's recently unveiled new development policy," Politico's Laura Rozen reports on her blog, which examines reaction to President Barack Obama's speech at the U.N. Summit on the Millennium Development Goals (MDGs) last week.
Adoption of health information technology is examined as new computer application development and adoption change how doctors deliver care.
On March 28, leading experts across multiple disciplines will convene at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes to review the latest research on bariatric surgery as a treatment option.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).
Atherosclerosis is a disease of the major arterial blood vessels. It is one of the major causes of heart attack and stroke. The proinflammatory molecule IL-1 has been linked to atherosclerosis and a clinical trial has been launched in which an antibody specific for IL-1-beta is being studied for its effects on the severe clinical complications of atherosclerosis.
› Verified 5 days ago
| Provider Name | Nadine Marie Nord |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1962144592 PECOS PAC ID: 9234526807 Enrollment ID: I20220428002598 |
News Archive
"The U.S. development community is pronouncing itself 'thrilled' with the Obama administration's recently unveiled new development policy," Politico's Laura Rozen reports on her blog, which examines reaction to President Barack Obama's speech at the U.N. Summit on the Millennium Development Goals (MDGs) last week.
Adoption of health information technology is examined as new computer application development and adoption change how doctors deliver care.
On March 28, leading experts across multiple disciplines will convene at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes to review the latest research on bariatric surgery as a treatment option.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).
Atherosclerosis is a disease of the major arterial blood vessels. It is one of the major causes of heart attack and stroke. The proinflammatory molecule IL-1 has been linked to atherosclerosis and a clinical trial has been launched in which an antibody specific for IL-1-beta is being studied for its effects on the severe clinical complications of atherosclerosis.
› Verified 5 days ago
| Provider Name | Stephen Eric Bradbery |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1730755851 PECOS PAC ID: 0042661654 Enrollment ID: I20240108006116 |
News Archive
"The U.S. development community is pronouncing itself 'thrilled' with the Obama administration's recently unveiled new development policy," Politico's Laura Rozen reports on her blog, which examines reaction to President Barack Obama's speech at the U.N. Summit on the Millennium Development Goals (MDGs) last week.
Adoption of health information technology is examined as new computer application development and adoption change how doctors deliver care.
On March 28, leading experts across multiple disciplines will convene at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes to review the latest research on bariatric surgery as a treatment option.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).
Atherosclerosis is a disease of the major arterial blood vessels. It is one of the major causes of heart attack and stroke. The proinflammatory molecule IL-1 has been linked to atherosclerosis and a clinical trial has been launched in which an antibody specific for IL-1-beta is being studied for its effects on the severe clinical complications of atherosclerosis.
› Verified 5 days ago
| Provider Name | Erin Ladwig |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1558984526 PECOS PAC ID: 8123461324 Enrollment ID: I20240205002347 |
News Archive
"The U.S. development community is pronouncing itself 'thrilled' with the Obama administration's recently unveiled new development policy," Politico's Laura Rozen reports on her blog, which examines reaction to President Barack Obama's speech at the U.N. Summit on the Millennium Development Goals (MDGs) last week.
Adoption of health information technology is examined as new computer application development and adoption change how doctors deliver care.
On March 28, leading experts across multiple disciplines will convene at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes to review the latest research on bariatric surgery as a treatment option.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).
Atherosclerosis is a disease of the major arterial blood vessels. It is one of the major causes of heart attack and stroke. The proinflammatory molecule IL-1 has been linked to atherosclerosis and a clinical trial has been launched in which an antibody specific for IL-1-beta is being studied for its effects on the severe clinical complications of atherosclerosis.
› Verified 5 days ago
| Provider Name | Mihaela Stoian |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1447031588 PECOS PAC ID: 0547605677 Enrollment ID: I20240228004482 |
News Archive
"The U.S. development community is pronouncing itself 'thrilled' with the Obama administration's recently unveiled new development policy," Politico's Laura Rozen reports on her blog, which examines reaction to President Barack Obama's speech at the U.N. Summit on the Millennium Development Goals (MDGs) last week.
Adoption of health information technology is examined as new computer application development and adoption change how doctors deliver care.
On March 28, leading experts across multiple disciplines will convene at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes to review the latest research on bariatric surgery as a treatment option.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).
Atherosclerosis is a disease of the major arterial blood vessels. It is one of the major causes of heart attack and stroke. The proinflammatory molecule IL-1 has been linked to atherosclerosis and a clinical trial has been launched in which an antibody specific for IL-1-beta is being studied for its effects on the severe clinical complications of atherosclerosis.
› Verified 5 days ago
News Archive
"The U.S. development community is pronouncing itself 'thrilled' with the Obama administration's recently unveiled new development policy," Politico's Laura Rozen reports on her blog, which examines reaction to President Barack Obama's speech at the U.N. Summit on the Millennium Development Goals (MDGs) last week.
Adoption of health information technology is examined as new computer application development and adoption change how doctors deliver care.
On March 28, leading experts across multiple disciplines will convene at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes to review the latest research on bariatric surgery as a treatment option.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).
Atherosclerosis is a disease of the major arterial blood vessels. It is one of the major causes of heart attack and stroke. The proinflammatory molecule IL-1 has been linked to atherosclerosis and a clinical trial has been launched in which an antibody specific for IL-1-beta is being studied for its effects on the severe clinical complications of atherosclerosis.
› Verified 5 days ago
South Broward Hospital District Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1150 N 35th Ave Ste 525, Hollywood, FL 33021 Phone: 954-265-6966 Fax: 954-265-6950 | |
Reclamation Center, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6966 Taft St, Hollywood, FL 33024 Phone: 954-432-8831 Fax: 954-432-8832 | |
Our Children Our Future, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 450 N Park Rd, Suite 600, Hollywood, FL 33021 Phone: 954-929-7515 Fax: 954-929-7510 | |
Serenity Behavioral Health Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2303 Hollywood Blvd, Suite 12, Hollywood, FL 33020 Phone: 954-367-7944 Fax: 954-374-8311 | |
My Choice Individual And Family Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2900 Dorchester Ln, Hollywood, FL 33026 Phone: 954-864-4552 | |
Live Free Wellness Institute Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7709 Davie Road Ext, Hollywood, FL 33024 Phone: 305-336-1739 | |
Goddess Health & Wellness, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5420 Hollywood Blvd Apt 111, Hollywood, FL 33021 Phone: 754-300-7591 Fax: 954-206-0496 |